Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China flag China · Delayed Price · Currency is CNY
23.06
-0.10 (-0.43%)
Nov 18, 2025, 3:00 PM CST

SHA:688319 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
169.67224.16362.07269.23254.37103.98
Upgrade
Trading Asset Securities
47.617.509020010
Upgrade
Cash & Short-Term Investments
217.27241.66362.07359.23454.37113.98
Upgrade
Cash Growth
-19.37%-33.26%0.79%-20.94%298.63%19.21%
Upgrade
Accounts Receivable
665.08570.35491.55491.69342.52192.26
Upgrade
Other Receivables
2.6211.13.781.10.81
Upgrade
Receivables
667.71571.35492.65495.48343.62193.06
Upgrade
Inventory
68.885.6872.1278.5274.546
Upgrade
Prepaid Expenses
--000.06-
Upgrade
Other Current Assets
10.449.454.352.662.429.71
Upgrade
Total Current Assets
964.22908.14931.19935.89874.98362.76
Upgrade
Property, Plant & Equipment
603.49572.3425.87378.35259.27240.39
Upgrade
Other Intangible Assets
17.2416.3316.8217.5113.7812.22
Upgrade
Long-Term Deferred Tax Assets
22.7218.2114.079.567.11-
Upgrade
Long-Term Deferred Charges
336.73291.5195.76132.3134.9319.74
Upgrade
Other Long-Term Assets
0.580.5628.895.2421.826.15
Upgrade
Total Assets
1,9451,8071,6131,4791,212641.26
Upgrade
Accounts Payable
116.3386.2940.0680.6834.2833.08
Upgrade
Accrued Expenses
0.45368.06346.13321.65251.98167.58
Upgrade
Short-Term Debt
2024.224.2853525
Upgrade
Current Portion of Long-Term Debt
78.787.4231.6910--
Upgrade
Current Income Taxes Payable
9.129.443.749.464.03-
Upgrade
Current Unearned Revenue
2.120.513.626.717.52.56
Upgrade
Other Current Liabilities
405.6719.6726.7911.738.8811.6
Upgrade
Total Current Liabilities
632.39595.59476.22525.23341.66239.83
Upgrade
Long-Term Debt
289.33249.53177.2929.99--
Upgrade
Long-Term Leases
8.650.644.439.043.252.49
Upgrade
Long-Term Unearned Revenue
26.3524.7919.9820.1118.6719.13
Upgrade
Long-Term Deferred Tax Liabilities
8.262.462.722.562.3-
Upgrade
Other Long-Term Liabilities
11.650.531.210.091.332.84
Upgrade
Total Liabilities
976.63873.54681.84587.02367.22264.29
Upgrade
Common Stock
405.93405.93406.16405.27405.27364.74
Upgrade
Additional Paid-In Capital
593.69606605.75580.95570.56251.37
Upgrade
Retained Earnings
-34.22-81.7-87.04-104.59-131.17-239.13
Upgrade
Treasury Stock
-5.56-5.56-7.96---
Upgrade
Total Common Equity
959.85924.68916.91881.63844.66376.97
Upgrade
Minority Interest
8.498.8213.8610.22--
Upgrade
Shareholders' Equity
968.34933.5930.77891.85844.66376.97
Upgrade
Total Liabilities & Equity
1,9451,8071,6131,4791,212641.26
Upgrade
Total Debt
396.68361.79237.61134.0338.2527.49
Upgrade
Net Cash (Debt)
-179.41-120.13124.47225.2416.1186.49
Upgrade
Net Cash Growth
---44.73%-45.88%381.08%0.86%
Upgrade
Net Cash Per Share
-0.44-0.300.310.561.080.24
Upgrade
Filing Date Shares Outstanding
405.93405.93406.16405.27405.27364.74
Upgrade
Total Common Shares Outstanding
405.93405.93406.16405.27405.27364.74
Upgrade
Working Capital
331.83312.55454.97410.67533.31122.93
Upgrade
Book Value Per Share
2.362.282.262.182.081.03
Upgrade
Tangible Book Value
942.6908.35900.08864.11830.88364.75
Upgrade
Tangible Book Value Per Share
2.322.242.222.132.051.00
Upgrade
Buildings
-224.6996.22103.17103.17-
Upgrade
Machinery
-318.26299.39261.88245.29-
Upgrade
Construction In Progress
-211.27181.35135.4911.63-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.